VLTO Stock Analysis: Veralto | NYSE

Pollution & Treatment Controls | NYSE, USA | Market Cap: 28.338m USD | 12M Return: 20.7% | US92338C1036 | Charts, Fundamentals & Technical Analysis

Water Analytics, Marking Systems, Color Management, Packaging Software
Total Rating 78
Safety 89
Buy Signal 2.13
Environmental & Facilities Services
Sub-Industry Rotation: +14.9
Market Cap: 28.3B
Avg Turnover: 208M
Risk 3d forecast
Volatility21.9%
VaR 5th Pctl3.58%
VaR vs Median-0.64%
Reward TTM
Sharpe Ratio0.73
Rel. Str. IBD88.2
Rel. Str. Peer Group97.9 pctl
Character TTM
Beta0.297
Beta Downside0.312
Hurst Exponent0.433
Choppyness32.7%
Drawdowns 3y
Max DD27.09%
CAGR/Max DD0.71
CAGR/Mean DD2.00
EPS (Earnings per Share) EPS (Earnings per Share) of VLTO over the last years for every Quarter: "2021-12": null, "2022-03": null, "2022-06": null, "2022-09": null, "2022-12": null, "2023-03": null, "2023-06": 0.79, "2023-09": 0.75, "2023-12": 0.87, "2024-03": 0.84, "2024-06": 0.85, "2024-09": 0.89, "2024-12": 0.95, "2025-03": 0.95, "2025-06": 0.93, "2025-09": 0.99, "2025-12": 1.04, "2026-03": 1.07, "2026-06": 1.11, "2026-09": 1.18,
Last SUE: 3.46
Qual. Beats: 5
Revenue Revenue of VLTO over the last years for every Quarter: 2021-12: 4700, 2022-03: 1172, 2022-06: 1231, 2022-09: 1219, 2022-12: 1257, 2023-03: 1225, 2023-06: 1253, 2023-09: 1255, 2023-12: 1288, 2024-03: 1246, 2024-06: 1288, 2024-09: 1314, 2024-12: 1345, 2025-03: 1332, 2025-06: 1371, 2025-09: 1404, 2025-12: 1396, 2026-03: 1422, 2026-06: 1474, 2026-09: 1509,
Rev. CAGR: 5.56%
Rev. Trend: 99.2%
Last SUE: 0.62
Qual. Beats: 0

Warnings

No concerns identified

Tailwinds

Supp Ema8
Rs Leader
Idiosyncratic Leader
Confidence
Tailwind

Seasonality 3.1 years of data, until 10/2026

Jan -0.3% 0
Feb -1.1% 0
Mar -2.5% 20
Apr +0.3% 0
May -0.1% 0
Jun -0.2% 0
Jul +6.8% 20
Aug +3.3% 20
Sep -1.0% 0
Oct -7.5% 7
Nov +6.2% 20
Dec -0.8% 0

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.

Description: VLTO Veralto

Veralto Corporation (NYSE: VLTO) is an industrial technology company that provides water analytics, water treatment, marking and coding, and packaging and color solutions to customers worldwide. The company operates through two reportable segments: Water Quality (WQ) and Product Quality & Innovation (PQI), serving end markets such as municipal utilities, food and beverage, pharmaceutical, and industrial customers.

The WQ segment supplies precision instrumentation, water treatment technologies, chemical reagents, services, and software for residential, commercial, municipal, industrial, research, and natural resource applications under brands such as Hach, Trojan Technologies, and ChemTreat. The PQI segment delivers marking and coding systems, digital asset and product information management software, inline printing solutions, packaging design software, and color management solutions under the Videojet, Linx, Esko, X-Rite, and Pantone brands. Many of these offerings (such as the Pantone color standards and Hach water analysis instruments) are recognized category leaders, reflecting a business model built on mission-critical, recurring or specification-driven demand rather than purely discretionary spending.

Veralto was incorporated in 2022 and is headquartered in Waltham, Massachusetts. The company was formerly known as DH EAS Holding Corp. and was spun off from Danaher Corporation, beginning trading on the NYSE on October 4, 2023, under its current name, which it adopted in February 2023. The company is classified within the GICS Industrials sector, specifically the Environmental & Facilities Services sub-industry, a categorization that reflects the central role of regulatory-driven water quality and environmental compliance in its revenue base.

Headlines to Watch Out For
  • PFAS and lead regulations boost municipal water treatment demand
  • Infrastructure bill funding expands municipal utility segment revenue
  • Esko and X-Rite software margins lift consolidated profitability
Piotroski VR-10 (Strict) 7.0
Net Income: 1.00b TTM > 0 and > 6% of Revenue
FCF/TA: 0.13 > 0.02 and ΔFCF/TA 0.02 > 1.0
NWC/Revenue: 29.08% < 20% (prev 21.24%; Δ 7.84% < -1%)
CFO/TA 0.14 > 3% & CFO 1.16b > Net Income 1.00b
Net Debt (1.34b) to EBITDA (1.37b): 0.98 < 3
Current Ratio: 2.03 > 1.5 & < 3
Outstanding Shares: last quarter (245.3m) vs 12m ago -2.11% < -2%
Gross Margin: 60.20% > 18% (prev 60.01%; Δ 0.18% > 0.5%)
Asset Turnover: 74.12% > 50% (prev 73.39%; Δ 0.74% > 0%)
Interest Coverage Ratio: 13.24 > 6 (EBIT TTM 1.27b / Interest Expense TTM 96.0m)
Altman Z'' 4.07
A: 0.21 (Total Current Assets 3.33b - Total Current Liabilities 1.64b) / Total Assets 8.22b
B: 0.29 (Retained Earnings 2.40b / Total Assets 8.22b)
C: 0.16 (EBIT TTM 1.27b / Avg Total Assets 7.83b)
D: 0.65 (Book Value of Equity 3.23b / Total Liabilities 4.99b)
Altman-Z'' = 4.07 = AA
Beneish M -2.98
DSRI: 1.00 (Receivables 927.0m/875.0m, Revenue 5.80b/5.45b)
GMI: 1.00 (GM 60.01% / 60.20%)
AQI: 1.01 (AQ_t 0.54 / AQ_t-1 0.53)
SGI: 1.06 (Revenue 5.80b / 5.45b)
TATA: -0.02 (NI 1.00b - CFO 1.16b) / TA 8.22b)
Beneish M = -2.98 (Cap -4..+1) = A
What is the price of VLTO shares?

As of November 16, 2026, the stock is trading at USD 118.25 with a total of 1,504,179 shares traded. Over the past week, the price has changed by +0.99%, over one month by +19.46%, over three months by +21.40% and over the past year by +20.65%.

Current recommended Stop Loss: 114.80 (which is 2.9% or 1.3 ATR below the current price).

Is VLTO a buy, sell or hold?

Veralto has received a consensus analysts rating of 4.18. Therefore, it is recommended to buy VLTO.

  • StrongBuy: 9
  • Buy: 2
  • Hold: 6
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the VLTO price?
Analysts Target Price 124.6 5.4%
Veralto (VLTO) - Fundamental Data Overview as of 07 November 2026
Market Cap USD = 28.3b (28.3b USD * 1.0 USD.USD)
P/E Trailing = 28.7778
P/E Forward = 24.2131
P/S = 4.8851
P/B = 8.7534
P/EG = 2.7538
Revenue TTM = 5.80b USD
EBIT TTM = 1.27b USD
EBITDA TTM = 1.37b USD
Long Term Debt = 2.67b USD (from longTermDebt, last quarter)
Short Term Debt = 249.0m USD (from shortTermDebt, last quarter)
Debt = 3.13b USD (from shortLongTermDebtTotal, last quarter) + Leases 206.0m
Net Debt = 1.34b USD (calculated: Debt 3.13b - CCE 1.78b)
Enterprise Value = 29.7b USD (28.3b + Debt 3.13b - CCE 1.78b)
Interest Coverage Ratio = 13.24 (Ebit TTM 1.27b / Interest Expense TTM 96.0m)
EV/FCF = 27.15x (Enterprise Value 29.7b / FCF TTM 1.09b)
FCF Yield = 3.68% (FCF TTM 1.09b / Enterprise Value 29.7b)
FCF Margin = 18.84% (FCF TTM 1.09b / Revenue TTM 5.80b)
Net Margin = 17.27% (Net Income TTM 1.00b / Revenue TTM 5.80b)
Gross Margin = 60.20% ((Revenue TTM 5.80b - Cost of Revenue TTM 2.31b) / Revenue TTM)
Gross Margin QoQ = 60.17% (prev 61.19%)
Tobins Q-Ratio = 3.61 (Enterprise Value 29.7b / Total Assets 8.22b)
Interest Expense / Debt = 3.07% (Interest Expense 96.0m / Debt 3.13b)
Taxrate = 14.80% (174.0m / 1.18b)
NOPAT = 1.08b (EBIT 1.27b * (1 - 14.80%))
Current Ratio = 2.03 (Total Current Assets 3.33b / Total Current Liabilities 1.64b)
Debt / Equity = 0.97 (Debt 3.13b / totalStockholderEquity, last quarter 3.23b)
Debt / EBITDA = 0.98 (Net Debt 1.34b / EBITDA 1.37b)
Debt / FCF = 1.23 (Net Debt 1.34b / FCF TTM 1.09b)
Total Stockholder Equity = 3.11b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.80% (Net Income 1.00b / Total Assets 8.22b)
RoE = 32.22% (Net Income TTM 1.00b / Total Stockholder Equity 3.11b)
RoCE = 21.99% (EBIT 1.27b / Capital Employed (Equity 3.11b + L.T.Debt 2.67b))
RoIC = 16.55% (NOPAT 1.08b / Invested Capital 6.54b)
WACC = 6.24% (E(28.3b)/V(31.5b) * Re(6.64%) + D(3.13b)/V(31.5b) * Rd(3.07%) * (1-Tc(0.15)))
Discount Rate = 6.64% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -65.64 | Cagr: -0.72%
[DCF] Terminal Value 76.76% ; FCFF base≈1.05b ; Y1≈1.15b ; Y5≈1.45b
[DCF] Fair Price = 85.35 (EV 22.1b - Net Debt 1.34b = Equity 20.8b / Shares 243.1m; r=8.35% [WACC [floored]]; 5y FCF grow 10.85% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 3.46 | # QB: 5
Revenue Correlation: 99.25 | Revenue CAGR: 5.56% | SUE: 0.62 | # QB: 0
EPS current Quarter (2027-03-31): EPS=1.18 | Chg30d=+2.32% | Revisions=+58% | Analysts=9
EPS current Year (2026-12-31): EPS=4.51 | Chg30d=+2.41% | Revisions=+0% | GrowthEPS=+15.6% | GrowthRev=+8.0%
EPS next Year (2027-12-31): EPS=4.88 | Chg30d=+1.91% | Revisions=+38% | GrowthEPS=+8.2% | GrowthRev=+5.2%
[Analyst] Revisions Ratio: +53% (up=13, down=3)